<DOC>
	<DOCNO>NCT00259389</DOCNO>
	<brief_summary>Adherence doctor-prescribed anti-HIV drug regimen crucial management HIV infection . In previous study tuberculosis patient , directly observe therapy ( DOT ) , strategy patient observe take medication , proven useful increase patient adherence . The purpose study determine effectiveness new DOT strategy HIV infect adolescent difficulty adhere anti-HIV drug regimen regimens prevent opportunistic infection ( OIs ) past .</brief_summary>
	<brief_title>Directly Observed Therapy HIV Infected Adolescents</brief_title>
	<detailed_description>For HIV infected people , control HIV infection best achieve adhere highly active antiretroviral therapy ( HAART ) regimen prescribe doctor . Poor adherence HAART regimen lead clinical failure development resistance . Many HIV infect adolescent difficulty adhere prescribe anti-HIV regimen OI prophylaxis ; often , cite forget take medication reason poor adherence . This pilot study use DOT assess adherence DOT HIV infect adolescent difficulty adhere HAART regimens past . The purpose study evaluate efficacy increase patient adherence feasibility use DOT among HIV infect adolescent . This study last 24 week . For first 2 week study , DOT provide 7 day week study site ; participant visit study site daily observe take medication . For next 6 week , frequency DOT reduce 7 day week 5 day week . Based adherence Weeks 4 8 , participant recommend continue DOT strategy follow : - Adherence Level 1 ( great 93 % ) - DOT 3 day week - Adherence Level 2 ( 86 % 93 % ) - DOT 5 day week - Adherence Level 3 ( less 86 % ) - DOT 7 day week Participants decide whether accept DOT assignment continue study . At Week 12 every 4 week thereafter , adherence assess DOT may adjust follow : - Adherence Level 1 - Reduce frequency DOT . Those already receive DOT 3 day week stop DOT start self-administered therapy . - Adherence Level 2 - Keep frequency DOT past 4 week . - Adherence Level 3 - Increase frequency DOT one level , describe previous list . HAART provide study , participant must access HAART medication coordinate separately study site . Participants take medication require twice-daily dose self-administer second dos . There 7 study visit ; occur study entry every 4 week thereafter . Medical history occur study entry . At every visit , participant ' adherence regimen assess , also interview social worker use support service . Participants undergo several assessment study entry Weeks 12 24 determine participant confidence , beliefs medicine , severity depression , feeling hopelessness , cop response , emotional behavioral problem . Blood collection occur study entry Weeks 8 , 12 , 24 . When participant successfully complete prescribed course DOT elect discontinue DOT , interview study staff .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Infected HIV age 12 Initiating , continue , change , reinitiating daily twicedaily HAART regimen AND demonstrate adherence problem ( less 85 % prescribed dose take , clinically disclose , 2 consecutive occasion least 1 month apart ) . More information criterion find protocol . Able willing swallow medication Have access HAART Parent guardian willing provide inform consent , applicable Willing use acceptable form contraception Clinically significant disease HIV infection clinically significant finding screen physical examination , opinion investigator , would require much close followup frequent monitoring would generally do HIV infect patient comparable age HAART regimens include medication take often twicedaily Investigational agent ( HAART medication ) administer part clinical trial Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Treatment Experienced</keyword>
	<keyword>Adherence</keyword>
	<keyword>Compliance</keyword>
	<keyword>Directly Observed Therapy</keyword>
	<keyword>DOT</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>